Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Nephrology
•
Glomerulonephritis
How would you tailor immunosuppression in an elderly patient presenting with primary FSGS?
Answer from: at Community Practice
Would use less [or avoid] high dose glucocorticoids. Rituximab would be preferred approach. Other options include CNIs and MMF.
Sign In
or
Register
to read more
28416
Related Questions
Has your management of post-transplant FSGS changed with the advent of new FSGS directed therapies?
How would you treat idiopathic isolated renal TMA diagnosed on renal biopsy without evidence of MAHA?
Would you consider using a combination regimen of rituximab, low-dose cyclophosphamide, and steroids to improve complete remission rates in patient with PLA2R-positive membranous nephropathy?
Would you consider initiating eculizumab without plasmapheresis as initial therapy for a patient with renal TMA who has a low suspicion of TTP based on a scoring algorithm?
How long would you wait before performing a kidney biopsy in a patient with nephrotic range proteinuria, a negative PLA2R antibody, a negative anti-THSD7A antibody, and stable renal function who recently started treatment a week ago with a DOAC for a pulmonary embolism?
Would you pursue a kidney biopsy in a patient with stable stage 1 AKI, bland urine sediment, and a positive MPO titer without systemic signs of vasculitis?
What factors do you consider when deciding to treat IgA nephropathy with immunosuppression in a patient with cirrhosis, given the possibility that IgA nephropathy could be secondary to cirrhosis?
How often do you check fibrinogen levels and when do you administer FFP for patients with AKI requiring plasma exchange?
How do you counsel patients who are found to have a carrier mutation in a single high-risk APOL1 allele?
How would you approach the treatment of crescentic fibrillary glomerulonephritis?